Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Circulation. Cardiovascular Interventions|January 6, 2011
Impact of drug-eluting stents and diabetes mellitus in patients with coronary bifurcation lesions: a survey from the Italian Society of Invasive CardiologyDavide Capodanno, Corrado Tamburino, Giuseppe M Sangiorgi, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|March 7, 2023
Secondary prevention and follow-up of patients with ACS and not-at-target LDL: An Italian real-world retro-prospective analysis by the inertia groupMaurizio Del Pinto, Francesco Amico, Natale Brunetti, et al.
American Heart Journal|September 10, 2010
Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS)Enrico Romagnoli, Stefano De Servi, Corrado Tamburino, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2012
Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) scoreGiuseppe Biondi-Zoccai, Enrico Romagnoli, Davide Castagno, et al.
International Journal of Cardiology|September 22, 2012
Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patientsSara Roversi, Giuseppe Biondi-Zoccai, Enrico Romagnoli, et al.
Atherosclerosis|January 25, 2023
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT)Paola Gargiulo, Christian Basile, Arturo Cesaro, et al.
European Journal of Preventive Cardiology|May 24, 2024
Strike early-strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registryPaola Gargiulo, Christian Basile, Gennaro Galasso, et al.
Pageof 3